Restless Leg Syndrome Market Outlook 2025: Detailed Trends, Size & Share Analysis

29 Apr, 2025

The Restless Leg Syndrome Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the Restless Leg Syndrome Market?

The market size of the restless leg syndrome has seen a quick expansion in recent years. In 2024, it was at $1.91 billion and is projected to increase to $2.17 billion in 2025, with a compound annual growth rate (CAGR) of 13.8%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Restless Leg Syndrome Industry?

The Restless Leg Syndrome Global Market is projected to reach a market size of $3.59 billion in 2029, with a compound annual growth rate (CAGR) of 13.4%.

Download Your Free Sample of the 2025 Restless Leg Syndrome Market Report and Uncover Key Trends Now!

What are the Key Growth Drivers Fueling the Restless Leg Syndrome Market?

The key drivers in the restless leg syndrome market are:

• Rise in healthcare investments
• Increased awareness and education campaigns
• Surge in early diagnosis
• Growth in government funding

Global Market Segmentation: Identifying Major Restless Leg Syndrome Industry Segments

The restless leg syndrome market covered in this report is segmented –
1) By Type: Primary Restless Legs Syndrome, Secondary Restless Legs Syndrome
2) By Treatment Type: Medicine And Devices, Surgery
3) By Route Of Administration: Oral, Injectable
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By Application: Neurological Treatment, Sleep Disorders, Movement Disorders, Symptom Management Subsegments:
1) By Primary Restless Legs Syndrome: Idiopathic Restless Legs Syndrome, Hereditary Restless Legs Syndrome
2) By Secondary Restless Legs Syndrome: Iron Deficiency-related Restless Legs Syndrome, Chronic Kidney Disease-related Restless Legs Syndrome, Pregnancy-related Restless Legs Syndrome, Medication-induced Restless Legs Syndrome

Pre-order the 2025 Restless Leg Syndrome Global Market Report for Fast Delivery & Comprehensive Insights!

What are the emerging Trends Shaping the Future of the Restless Leg Syndrome Market?

The key trends in the restless leg syndrome market are:

• The trend of AI-powered personalized treatment plans is shaping the future of the Restless Leg Syndrome market.
• There is an emerging trend of employing next-generation neurostimulation devices.
• Deep learning algorithms are being increasingly used for diagnosis.
• Brainwave modulation technology and wearable exoskeletons for leg movements are significant upcoming trends.

Who Are the Top Competitors & Leading Players in the Restless Leg Syndrome Market?

Major players in the restless leg syndrome market are:

• Pfizer Inc.
• Roche Holding AG
• Merck & Co Inc.
• Novartis International AG
• GlaxoSmithKline plc
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Baxter International Inc.
• Astellas Pharma Inc.
• UCB S.A.
• Kyowa Kirin Co Ltd.
• Amneal Pharmaceuticals Inc.
• Lupin Pharmaceuticals Inc.
• Alembic Pharmaceuticals Limited
• Mundipharma International Limited
• Azurity Pharmaceuticals LLC
• Otsuka Pharmaceutical Co Ltd.
• Horizon Therapeutics plc
• Mylan N.V.
• Apollo Pharmacy Limited

Regional Dominance: Which Area Leads the Global Template Market?

Europe was the largest region in the restless leg syndrome market in 2024